… that in patients with T2D, weight loss reduces the risk of … loss via urinary glucose excretion
and mild osmotic diuresis,[Citation47] the patients in the present analysis had body weight …

… % weight loss during the last 3 months before enrollment); significant renal, hepatic,
hematological, oncological, endocrine, psychiatric, or rheumatic diseases, a cardiovascular event (…

… Benefits of dapagliflozin treatment projected for microvascular outcomes varied based on
the relative importance of glucose, BP and weight control to these conditions. In sensitivity …

… dapagliflozin were able to stop or reduce one or more other diabetes medications. Conclusions:
Dapagliflozin is … It also reduces blood pressure, results in weight loss, and reduces the …

… between the estimated and actual weight loss because of dapagliflozin treatment in a
randomized, double-blind, placebo-controlled, cross-over trial. The results showed that …

… obesity lose weight when treated with dapagliflozin (∼4%), … to vehicle-treated animals leads
to greater weight loss of ∼13… occurs that limits the weight loss in dapagliflozin treatment; the …

… and 799 (67.7%) achieved both HbA1c lowering and body weight loss. More than a third of
the patients in the 12-week dapagliflozin treatment group (761/2007; 37.9%) experienced ≥ …

… , whereby the benefit of this treatment was greater in patients with larger waist … a treatment
anticipated to cause modest weight loss, 15, 16 according to baseline BMI in the Dapagliflozin …

… maintenance of body weight loss.6 While pharmacological treatments may augment initial
body weight loss and/or maintenance of body weight loss alongside behavioural interventions…

… Some patients might achieve both goals of blood glucose loss and weight loss after
SGLT2i prescription 8, 9 . On the contrary, there will certainly be patients with increased blood …